A step towards more potent vaccines
Ziba Kashef
Senior Writer, Editor and Communications Consultant, Yale University Office of Public Affairs and CommunicationsYale researchers uncovered a new role for a type of immune cell, known as regulatory T cells, in promoting long-term immunity. The new insight gets researchers one step closer to developing vaccines that could be more protective against some of the most intractable viral infections, including HIV and flu.
For the study, published in Nature Immunology, researchers Brian Laidlaw, Dr. Joseph Craft, and Dr. Susan M. Kaech and co-authors observed immune responses to infection in mouse models. They found that a chemical signal known as IL-10, which is secreted by regulatory T cells, is important for the development of long-term immunity.
IL-10 is particularly important for keeping inflammation in check during the resolution phase of infection. By reducing inflammation during this phase, IL-10 enabled long-term memory cells — CD8+ T cells — to mature and develop their capacity to protect against future infection.
The finding may hold the key to more effective vaccines. “A critical problem with many vaccines is that they do not elicit a robust and protective T cell response,” said Laidlaw. The study sheds light on another pathway for enhancing the body’s protective response. “By understanding this process, during each phase of the immune response, we hope to be able to mirror these steps in a vaccine approach,” he said.
This article is published in collaboration with Yale News. Publication does not imply endorsement of views by the World Economic Forum.
To keep up with the Agenda subscribe to our weekly newsletter.
Author: Ziba Kashef is a Senior Writer, Editor and Communications Consultant.
Image: A health worker displays bottles of vaccines. REUTERS/Rupak De Chowdhuri.
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Stay up to date:
Future of Global Health and Healthcare
Related topics:
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
More on Emerging TechnologiesSee all
Hope French and Michael Atkinson
November 7, 2024